![Jeff Jonas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeff Jonas
Directeur/Bestuurslid bij
COMPASS PATHWAYS PLC
Vermogen: - $ op 31-05-2026
Profiel
Jeffrey M. Jonas richtte AVAX Technologies, Inc. en Evogen, Inc. op. Hij is directeur en Chief Innovation Officer bij SAGE Therapeutics, Inc. Dr. Jonas zit ook in de raad van bestuur van Pharmaceutical Research & Manufacturers of America, Karuna Therapeutics, Inc. en Generation Bio Co. Daarvoor was hij voorzitter, president en chief executive officer van Evogen, Inc., president, chief executive officer en directeur van AVAX Technologies, Inc., vice-president onderzoek en klinische ontwikkeling van Upjohn Laboratories LLC, executive vice-president van Ionis Pharmaceuticals, Inc., president van Shire Regenerative Medicine, Inc., chief medical officer en executive vice-president van Forest Laboratories, Inc., president van de divisie regeneratieve geneeskunde van Shire Plc, hoofdassistent in het McLean Hospital, Inc. en hoofdassistent in de Harvard Medical School. Hij behaalde zijn doctoraal aan het Amherst College en zijn doctoraal aan de Harvard Medical School.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
COMPASS PATHWAYS PLC -.--% | 27-05-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
Actieve functies van Jeff Jonas
| Bedrijven | Functie | Begin |
|---|---|---|
| COMPASS PATHWAYS PLC | Directeur/Bestuurslid | 29-10-2025 |
Ryne Biotechnology, Inc.
 Ryne Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company for neuron replacement therapies for neurological conditions | Voorzitter | 01-02-2024 |
Cure Ventures Management LP
 Cure Ventures Management LP Investment ManagersFinance Cure Ventures invests in companies located in the United States. The firm targets companies operating in the fields of life science and biotechnology sectors. It provides financing for seed and early stage capital requirements. It acts as a lead investor and also makes follow-on investments. | Private Equity Investor | 01-01-2024 |
Angiocrine Bioscience, Inc.
 Angiocrine Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage cell and gene therapy company | Directeur/Bestuurslid | - |
Noema Pharma AG
 Noema Pharma AG Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotech company that provide therapeutics for central nervous system | Voorzitter | 04-10-2021 |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Directeur/Bestuurslid | - |
Eerdere bekende functies van Jeff Jonas
| Bedrijven | Functie | Einde |
|---|---|---|
| GENERATION BIO CO. | Directeur/Bestuurslid | 06-02-2026 |
| SAGE THERAPEUTICS, INC. | Algemeen Directeur | 15-12-2020 |
| KARA THER | Directeur/Bestuurslid | 18-03-2024 |
| ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Jeff Jonas
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
47
Eerstegraads connecties
24
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 24 |
|---|---|
Forest Laboratories, Inc.
 Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells drug products | Health Technology |
Ionis Pharmaceuticals, Inc.
 Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
AVAX Technologies, Inc.
 AVAX Technologies, Inc. BiotechnologyHealth Technology Operates as development stage company with interest in the development and future commercialization of individualized cancer vaccines | Health Technology |
Shire Plc /Old/
 Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets pharmaceuticals | Commercial Services |
Shire Regenerative Medicine, Inc.
 Shire Regenerative Medicine, Inc. BiotechnologyHealth Technology Manufactures biomedical products | Health Technology |
CARA Therapeutics, Inc.
 CARA Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes new chemical entities designed to fundamentally change the way acute pain, chronic pain and pruritus are managed | Health Technology |
Angiocrine Bioscience, Inc.
Angiocrine Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage cell and gene therapy company | Commercial Services |
Amherst College
 Amherst College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
McLean Hospital, Inc.
 McLean Hospital, Inc. Hospital/Nursing ManagementHealth Services Provides healthcare services | Health Services |
Evogen, Inc.
 Evogen, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops technology for biological and chemical defense systems | Electronic Technology |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Upjohn Laboratories LLC | |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Karuna Therapeutics, Inc.
 Karuna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicines for psychiatric and neurological disorders like schizophrenia and Alzheimer’s disease | Health Technology |
SAGE Therapeutics, Inc.
 SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
PureTech Health Plc
 PureTech Health Plc BiotechnologyHealth Technology Engages in the development of treatment programs for obesity, cognitive disorders, baldness, depression, allergy and autoimmune | Health Technology |
Decibel Therapeutics, Inc.
 Decibel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines for hearing and balance disorders | Health Technology |
Generation Bio Co.
 Generation Bio Co. Pharmaceuticals: MajorHealth Technology Develops and commercializes genetic medicines | Health Technology |
Compass Pathways Plc
 Compass Pathways Plc BiotechnologyHealth Technology Develops therapies and drugs for the treatment of mental health and neurocognitive conditions | Health Technology |
Cure Ventures Management LP
Cure Ventures Management LP Investment ManagersFinance Cure Ventures invests in companies located in the United States. The firm targets companies operating in the fields of life science and biotechnology sectors. It provides financing for seed and early stage capital requirements. It acts as a lead investor and also makes follow-on investments. | Finance |
Noema Pharma AG
Noema Pharma AG Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotech company that provide therapeutics for central nervous system | Commercial Services |
Ryne Biotechnology, Inc.
Ryne Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company for neuron replacement therapies for neurological conditions | Health Technology |
Abio-X Holdings, Inc. |
